These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10511295)

  • 1. Acyl coenzyme A: cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion.
    Burnett JR; Wilcox LJ; Huff MW
    Clin Chim Acta; 1999 Aug; 286(1-2):231-42. PubMed ID: 10511295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.
    Musanti R; Giorgini L; Lovisolo PP; Pirillo A; Chiari A; Ghiselli G
    J Lipid Res; 1996 Jan; 37(1):1-14. PubMed ID: 8820097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
    Carr TP; Hamilton RL; Rudel LL
    J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
    Brown A; Wiggins D; Gibbons GF
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Huff MW
    Biochim Biophys Acta; 1998 Jul; 1393(1):63-79. PubMed ID: 9714740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACAT2 stimulates cholesteryl ester secretion in apoB-containing lipoproteins.
    Temel RE; Hou L; Rudel LL; Shelness GS
    J Lipid Res; 2007 Jul; 48(7):1618-27. PubMed ID: 17438337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    J Lipid Res; 1999 Jul; 40(7):1317-27. PubMed ID: 10393217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
    Leon C; Hill JS; Wasan KM
    Pharm Res; 2005 Oct; 22(10):1578-88. PubMed ID: 16180116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of acyl coenzyme A cholesterol acyltransferase in intrahepatic processing of apo B-lipoprotein in suncus.
    Nagayoshi A; Matsuki N; Saito H; Kaneko K; Shimazu N; Suga S; Wakashima M; Kinoshita M; Yamanaka M; Teramoto T
    J Biochem; 1995 Aug; 118(2):259-64. PubMed ID: 8543556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatic ACAT decreases ApoB secretion in miniature pigs fed a cholesterol-free diet.
    Huff MW; Telford DE; Barrett PH; Billheimer JT; Gillies PJ
    Arterioscler Thromb; 1994 Sep; 14(9):1498-508. PubMed ID: 8068612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells.
    Liang JJ; Oelkers P; Guo C; Chu PC; Dixon JL; Ginsberg HN; Sturley SL
    J Biol Chem; 2004 Oct; 279(43):44938-44. PubMed ID: 15308631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
    Wilcox LJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP.
    Wilcox LJ; Borradaile NM; de Dreu LE; Huff MW
    J Lipid Res; 2001 May; 42(5):725-34. PubMed ID: 11352979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
    Graham A; Wood JL; Russell LJ
    Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl coenzyme A:cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs.
    Alegret M; Llaverias G; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004 Sep; 26(7):563-86. PubMed ID: 15538545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.
    Bell TA; Brown JM; Graham MJ; Lemonidis KM; Crooke RM; Rudel LL
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1814-20. PubMed ID: 16675724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.
    Taghibiglou C; Van Iderstine SC; Kulinski A; Rudy D; Adeli K
    Biochem Pharmacol; 2002 Feb; 63(3):349-60. PubMed ID: 11853686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of acyl-coenzyme A:cholesterol acyltransferase-1 in the control of hepatic very low density lipoprotein secretion and low density lipoprotein receptor expression in the mouse and hamster.
    Spady DK; Willard MN; Meidell RS
    J Biol Chem; 2000 Sep; 275(35):27005-12. PubMed ID: 10869364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness.
    Lada AT; Davis M; Kent C; Chapman J; Tomoda H; Omura S; Rudel LL
    J Lipid Res; 2004 Feb; 45(2):378-86. PubMed ID: 14617738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.